Le Lézard
Classified in: Health
Subject: CFG

Supporting health care providers through Lawson Health Research Institute


Improving health outcomes for people at risk of substance-related harms and overdose

LONDON, ON, March 25, 2024 /CNW/ - Canada is facing an unrelenting and tragic toxic illegal drug and overdose crisis. No community has been left untouched. The impacts are seen and felt among our friends, family and neighbours. That's why the Government of Canada is leveraging all the tools at its disposal to work towards an end to this national public health crisis?including efforts aimed at prevention, harm reduction, treatment, recovery and enforcement.

Today, Arielle Kayabaga, Member of Parliament for London West, on behalf of the Honourable Ya'ara Saks, Minister of Mental Health and Addictions and Associate Minister of Health, highlighted an investment of $72,768 to the Lawson Health Research Institute through Health Canada's Substance Use and Addictions Program (SUAP).

These funds have already helped St. Joseph's Health Care London and London Health Sciences Centre train health care and service providers to create tailored harm reduction strategies for people who use methamphetamine. This project, which has trained over 400 hospital staff to date, is helping increase staff's understanding of patients' lived experience, resulting in more approachable and compassionate care, as well as improved interactions between clients and health workers.

Supporting projects like this through SUAP is a key part of the renewed Canadian Drugs and Substances Strategy ? Canada's comprehensive response to substance-related harms and the overdose crisis in Canada. 

The Government of Canada will continue to work with all levels of government, public health and public safety partners, social sectors, Indigenous communities, stakeholders, people with lived and living experience, and community organizations across the country to support a full range of services, improve health outcomes for all Canadians and save lives.

Quotes

"Supporting local organizations who have deep roots in their communities and have the trust of their patients is making a real difference in people's lives in the community of London, Ontario. This investment is part of our comprehensive and compassionate approach to reducing harms as a result of substance use. We will continue to use every tool at our disposal to build a safer, healthier and more caring future for all Canadians."

The Honourable Ya'ara Saks
Minister of Mental Health and Addictions and Associate Minister of Health

"Here in London, just like many other cities across Canada, we're seeing substance use harms continue to take a tragic toll on our families and friends. We are committed to supporting organizations who are on the ground in communities, helping to keep people who use substances safe. There is no one size fits all solution to the toxic illegal drug and overdose crisis, but we will continue to work together to help save lives."

Arielle Kayabaga
Member of Parliament for London West

"This funding is allowing us to partner with health-care providers and those with lived experience of using methamphetamine to advance harm reduction in hospitals. We have gained new understanding of barriers to harm reduction like stigma and lack of knowledge, and we are testing educational approaches that are proving to be effective in improving safety and the patient experience." 

Dr. Cheryl Forchuk
Scientist and Assistant Scientific Director at Lawson Health Research Institute.

Quick Facts

 Associated Links

SOURCE Health Canada (HC)


These press releases may also interest you

at 22:51
Chemistree Technology Inc. and (US OTC: CHMJF) (the "Company" or "Chemistree"), announces that its board of directors (the "Board") has approved a restructuring transaction (the "Restructuring Transaction"), pursuant to which all of the principal of...

at 21:00
United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, will unveil its latest MRI technology, boasting incredible advancements across various fronts, as a Gold sponsor at this year's ISMRM meeting. The...

at 20:26
In the news release, Mitsubishi Tanabe Pharma America to Present RADICAVA ORS® (edaravone) Real-World Data at the Professional Society for Health Economics and Outcomes Research 2024 Annual Meeting, issued 03-May-2024 by Mitsubishi Tanabe Pharma...

at 20:00
Affiliated Dermatologists (AD) is providing notice of a recent data security incident. At this time, AD is not aware of any misuse of any personal information in connection with this incident. What Happened? On March 5, 2024, AD detected it was the...

at 19:19
With recent news of dairy cattle in the United States testing positive for the Highly Pathogenic Avian Influenza (HPAI) and reports of fragments of HPAI detected in pasteurized milk sold in the U.S., we understand that Canadians may be concerned...

at 19:01
Butterfly Medical Ltd, an early-stage medical device company focused on alleviating suffering in patients with BPH (Benign Prostatic Hyperplasia), is excited to announce the hiring of Patrick MacCarthy as CEO. ...



News published on and distributed by: